Ignite Creation Date:
2024-05-06 @ 2:55 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02169115
Status:
COMPLETED
Last Update Posted:
2020-11-03
First Post:
2014-06-12
Brief Title:
Urticaria Facticia Treatment With Omalizumab UFO
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Organization Data
Organization:
Charite University Berlin Germany
Class:
OTHER
Study ID:
CIGE025EDE17T
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Charite University Berlin Germany
Lead Sponsor Class:
OTHER
Responsible Party:
Martin Metz
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Charite University Berlin Germany
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis Pharmaceuticals | INDUSTRY |